In February 2025, President Trump’s threat of a 25 per cent tariff on Canadian products dominated Canadian news. Like management at many other Canadian businesses, Jill Conrod and Ciaro Moxey were trying to grasp the impact on their company, Novagevity. Novagevity produced Sperri, a meal replacement beverage that it sold to unwell and health conscious consumers, primarily in Canada. The company had just raised millions of dollars in support of a growth plan that included the United States, but now Conrod and Moxey were wondering about the best way forward. Sperri had taken several years to develop and launch. The company had subsequently achieved strong growth in Canada and had decided to expand to the United States. Even without the tariff, this was no small task. Should Novagevity rethink its US growth plans and focus on growth opportunities in Canada for now?
看看哪些人也有訂購？